Recombinant and tissue-derived mouse BM-40 bind to several collagen types and have increased affinities after proteolytic activation

Cellular and Molecular Life Sciences

Volumn 53, Issue 5, 1997, Pages 478-484

  Maurer, P ^a,b   Gohring W ^a   Sasaki, T ^a   Mann, K ^a   Timpl, R ^a   Nischt, R ^b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Calcium binding; Collagen affinity; Extracellular matrix; Kinetic analysis; Matrix metalloproteinase

Indexed keywords

CALCIUM BINDING PROTEIN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 5; COLLAGEN TYPE 6; EDETIC ACID; EPITOPE; RECOMBINANT PROTEIN; SCLEROPROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CELL CLONE; CIRCULAR DICHROISM; CONTROLLED STUDY; ELECTROPHORESIS; PROTEIN BINDING; PROTEIN DEGRADATION;

3T3 CELLS; ANIMALS; CELL LINE, TRANSFORMED; COLLAGEN; COLLAGENASES; HUMANS; MATRIX METALLOPROTEINASE 13; MICE; OSTEONECTIN; RECOMBINANT FUSION PROTEINS;

EID: 0030758452     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050059     Document Type: Article

References (34)

1. Sodek J. (1993) SPARC/osteonectin. In: Guidebook to the Extracellular Matrix and Adhesion Proteins, pp. 89-91, Kreis T. and Vale R. (eds), Oxford University Press
2. Lane T. F. and Sage E. H. (1994) The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8: 163-173
3. Maurer P., Mayer U., Bruch M., Jenö P., Mann K., Landwehr R. et al. (1992) High and low affinity calcium binding and stability of the multidomain extracellular glycoprotein BM-40/ SPARC/osteonectin. Eur. J. Biochem. 205: 233-240
4. Domenicucci C., Goldberg H. A., Hofmann T., Isenmann D., Wasi S. and Sodek J. (1988) Characterization of porcine osteonectin extracted from foetal calvariae. Biochem. J. 253: 139-151
5. 2 + -dependent binding to the extracellular matrix. J. Cell Biol. 109: 341-356
6. Mayer U., Aumailley M., Mann K., Timpl R. and Engel J. (1991) Calcium-dependent binding of basement membrane protein BM-40 (osteonectin, SPARC) to basement membrane collagen type IV. Eur. J. Biochem. 198: 141-150
7. Nischt R., Pottgiesser J., Krieg T., Mayer U., Aumailley M. and Timpl R. (1991) Recombinant expression and properties of the human calcium-binding extracellular matrix protein BM-40. Eur. J. Biochem. 200: 529-536
8. Kelm R. J. and Mann K. G. (1991) The collagen binding specificity of bone and platelet osteonectin is related to differences in glycosylation. J. Biol. Chem. 266: 9632-9639
9. Maurer P., Hohenadl C., Hohenester E., Göhring W., Timpl R. and Engel J. (1995) The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV. J. Molec. Biol. 253: 347-357
10. 2 + -binding module in BM-40. Nature Struct. Biol. 3: 67-73
11. Sasaki T., Göhring W., Mann K., Maurer P., Hohenester E., Knäuper V. et al. (1997) Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J. Biol. Chem., 272: 9237-9243
12. Alliel P. M., Perin J.-P., Jollès P. and Bonnet F. J. (1993) Testican, a multidomain testicular proteoglycan resembling modulators of cell social behaviour. Eur. J. Biochem. 214: 347-350
13. Otsuka K., Yao K. L., Wasi S., Tung P. S., Aubin J. E., Sodek J. et al. (1984) Biosynthesis of osteonectin by fetal porcine calvarial cells in vitro. J. Biol. Chem. 259: 9805-9812
14. Bossard M. J., Tomaszek T. A., Thompson S. K., Amegadzie B. Y., Hanning C. R., Jones C. et al. (1996) Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J. Biol. Chem. 271: 12517-12524
15. Tyree B. (1989) The partial degradation of osteonectin by a bone-derived metalloprotease enhances binding to type 1 collagen. J. Bone Mineral Res. 4: 877-883
16. Mann K., Deutzmann R., Paulsson M. and Timpl R. (1987) Solubilization of protein BM-40 from a basement membrane tumour with chelating agents and evidence for its identity with osteonectin and SPARC. FEBS Lett. 218: 167-172
17. Miller E. J. and Rhodes R. K. (1982) Preparation and characterization of the different types of collagens. Meth. Enzym. 82: 33-64
18. Vandenberg P., Kern, A., Ries A., Luckenbill-Edds L., Mann K. and Kühn K. (1991) Characterization of a type IV collagen major cell binding site with affinity to the α1β1 and α2β1 20 integrins. J. Cell Biol. 113: 1475-1483
19. Odermatt E., Risteli J., van Delden V. and Timpl R. (1983) Structural diversity and domain composition of a unique collagenous fragment (intima collagen) obtained from human placenta. Biochem. J. 211: 295-302
20. Fertala A., Sieron A. L., Ganguly A., Li S.-W., Ala-Kokko L., Anumula K. R. et al. (1994) Synthesis of recombinant human procollagen II in a stably transfected tumour cell line (HT1080). Biochem. J. 298: 31-37
21. Knäuper V., Lopez-Otin C., Smith B., Knight G. and Murphy G. (1996) Biochemical characterization of human collagenase-3. J. Biol. Chem. 271: 1544-1550
22. r43000. EMBO J. 5: 1465-1472
23. Gorman C., Gies D. R. and McCray G. (1990) Transient production of proteins using an adenovirus transformed cell line. DNA Protein Eng. Tech. 2: 3-10
24. Tillet E., Wiedemann H., Golbik R., Pan T.-C., Zhang R.-Z., Mann K. et al. (1994) Recombinant expression and structural and binding properties of α1(VI) and α2(VI) chains of human collagen type VI. Eur. J. Biochem. 221: 177-185
25. Fägerstam L. G., Frostell-Karlsson A., Karlsson R., Persson B. and Rönnberg I. (1992) Biospecific interaction analysis using surface plasmon resonance detection applied to kinetic, binding site and concentration analysis. J. Chromat. 597: 397-410
26. Sasaki T., Wiedemann H., Matzner M., Chu M.-L. and Timpl R. (1996) Expression of fibulin-2 by fibroblasts and deposition with fibronectin into a fibrillar matrix. J. Cell Sci. 109: 2895-2904
27. Lankal-Buttgereit B., Mann K., Deutzmann R., Timpl R. and Krieg T. (1988) Cloning and complete amino acid sequences of human and murine basement membrane protein BM-40 (SPARC, osteonectin). FEBS Lett. 623: 352-356
28. Pottgiesser J., Maurer P., Mayer U., Nischt R., Mann K., Timpl R. et al. (1994) Changes in calcium and collagen IV binding caused by mutations in the EF hand and other domains of extracellular matrix protein BM-40 (SPARC, osteonectin). J. Molec. Biol. 238: 563-574
29. Xie R.-L. and Long G. L. (1995) Role of N-linked glycosylation in human osteonectin. Effect of removal by N-glycanase and site-directed mutagenesis on structure and binding of type V collagen. J. Biol. Chem. 270: 23212-23217
30. Knäuper V., Will H., Lopez-Otin C., Smith B., Atkinson S. J., Stanton H. et al. (1996) Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J. Biol. Chem. 271: 17124-17131
31. Iruela-Arispe M.-L., Lane T. F., Redmond D., Reilly M., Bolender R. P., Kavanagh T. J. et al. (1995) Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo. Molec. Biol. Cell 6: 327-343
32. Ledda F., Bravo A. I., Adris S., Bover L., Mordoh J. and Podhajcer O. L. (1997) The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J. Invest. Dermatol. 108: 210-214
33. Ledda M. F., Adris S., Bravo A. I., Kairiyania C., Bover L., Chernajovsky Y. et al. (1997) Suppression of SPARC expression by antisense RNA abrogates the tumourigenicity of human melanoma cells. Nature Med. 3: 171-176
34. Fosang A. J., Last K. and Maciewicz R. A. (1996) Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinases and aggrecanase activities can be independent. J. Clin. Invest. 98: 2292-2299